SEC Form 4 · accession 0001179110-16-026949
Blueprint Medicines Corp · BPMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Demetri
Director
Period of report
Jun 23, 2016
Accepted (ET)
Jun 27, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597264
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.53 | Jun 23, 2016 | A | 10,909 | A | — | Jun 23, 2026 | Common Stock | 10,909 | 46,362 | D |
Explanation of responses
- F1This option vests with respect to 100% of the shares underlying the option on the earlier of (i) the next annual meeting of the Issuer's stockholders and (ii) June 23, 2017.
Remarks
Exhibit 24 - Limited Power of Attorney